Autoimmune Disease Risk with GLP-1RA, DPP-4i and SGLT2i Treatment in Patients with Diabetes

In this episode, we explore research investigating the potential association between newer anti-diabetic medications and autoimmune diseases in patients with diabetes. Dr. Sparks and Arjun Mahajan discuss their innovative study using the TriNetX Global Collaborative Network, explaining their methods, key findings, clinical implications, and study limitations. They also share insights into the mentoring relationship that supported their research and highlight the importance of mentorship in advancing rheumatology research.